Global Micafungin Sodium for Injection Market Research Report 2021

Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.
In 2013, Japan was the largest consumption place, with a consumption market share nearly 35.40%. In 2017, North America is the largest consumption place with the consumption market share of 28.98%.

The global Micafungin Sodium for Injection market was valued at US$ 358.3 million in 2019 and is expected to reach US$ 301.7 million by the end of 2026, growing at a CAGR of -2.4% during 2021-2026.
This report focuses on Micafungin Sodium for Injection volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Micafungin Sodium for Injection market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Micafungin Sodium for Injection Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
50 mg Single-use Vial
100 mg Single-use Vial

Segment by Application
Candidemia
Respiratory Mycosis
Gastrointestinal Mycosis

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Astellas